Subtype
Multiple Endocrine Neoplasia Type 1
CI-CAN-00001240Explore in graph →
Non-malignant2 active trials
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001240Explore in graph →
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03950609 | Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors | active not recruiting | Phase 2 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT04969926 | Natural History Study of Parathyroid Disorders | recruiting | — | 3,000 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05037461 | Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients(PRIME) | active not recruiting | N/A | 20 | J.M. de LaatOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT03050268 |
Data updated 11 days agoSource updated Sep 18, 2026source: clinicaltrials
| Familial Investigations of Childhood Cancer Predisposition(SJFAMILY) |
| recruiting |
| — |
| 1,500 |
| St. Jude Children's Research HospitalOTHER |
| 1 |
| Jun 17, 2026 |
| clinicaltrials |
| NCT01793168 | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS) | recruiting | — | 20,000 | Sanford HealthOTHER | 2 | May 29, 2025 | clinicaltrials |
| NCT06790251 | Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database) | not yet recruiting | — | 600 | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo SettoreOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT06523582 | Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients | recruiting | — | 750 | Universidad Nacional Autonoma de MexicoOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT02753686 | Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy(Treat ER+ight) | completed | — | 440 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05554744 | EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors | unknown | N/A | 20 | Guangxi Medical UniversityOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT05061784 | Routine Transcervical Thymectomy in MEN-1 Patients | completed | — | 7 | National University Health System, SingaporeOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT03001349 | 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors | terminated | Early Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT00454363 | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2020 | clinicaltrials |
| NCT02101918 | Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Mar 23, 2020 | clinicaltrials |
| NCT02831179 | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Sep 28, 2017 | clinicaltrials |
| NCT01794676 | Genetic Evaluation of Families With Endocrine Cancers(MEN1) | completed | — | 9 | Jersey Shore University Medical CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |